Cargando…
Comparative performance of COVID-19 serology testing
BACKGROUND: The 2019 novel coronavirus infectious disease (COVID-19) pandemic resulted in a surge of assays aimed at detecting severe acute respiratory syndrome (SARS) – coronavirus (CoV) – 2 infection and prior exposure. Although both molecular and antigen testing have clearly defined uses, the uti...
Autores principales: | Tran, Nam K., May, Larissa, Cohen, Stuart H., Rodrigo, John, Gong, Raymond, Liu, Ying, Conner, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259022/ https://www.ncbi.nlm.nih.gov/pubmed/35818626 http://dx.doi.org/10.1016/j.plabm.2022.e00289 |
Ejemplares similares
-
Innovations in infectious disease testing: Leveraging COVID-19 pandemic technologies for the future
por: Tran, Nam K., et al.
Publicado: (2023) -
Comparative performance of two automated machine learning platforms for COVID-19 detection by MALDI-TOF-MS
por: Rashidi, Hooman H., et al.
Publicado: (2022) -
Diagnostic performance of commercially available COVID-19 serology tests in Brazil
por: Cota, Gláucia, et al.
Publicado: (2020) -
COVID-19 Serological Tests: How Well Do They Actually Perform?
por: Ghaffari, Abdi, et al.
Publicado: (2020) -
Update on serologic testing in COVID–19
por: Krajewski, Rafał, et al.
Publicado: (2020)